These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
127 related articles for article (PubMed ID: 32508161)
1. Zeng H; Zhu X; Tian Q; Yan Y; Zhang L; Yan M; Li R; Li X; Wang G; Ma J; Su Y; Zhang X; Ma L; Zhang Z; Wu X Drug Deliv; 2020 Dec; 27(1):848-854. PubMed ID: 32508161 [TBL] [Abstract][Full Text] [Related]
2. In vivo antitumor effects of chitosan-conjugated docetaxel after oral administration. Lee E; Kim H; Lee IH; Jon S J Control Release; 2009 Dec; 140(2):79-85. PubMed ID: 19712714 [TBL] [Abstract][Full Text] [Related]
3. TP-CSO: A Triptolide Prodrug for Pancreatic Cancer Treatment. Wang X; Zeng H; Zhu X; Xu D; Tian Q; Wang C; Zhao L; Zhao J; Miao M; Wu X Molecules; 2022 Jun; 27(12):. PubMed ID: 35744811 [TBL] [Abstract][Full Text] [Related]
4. ATB Lou D; Lou Z; Lin Y; Shangguan H; Lin Y; Luo Q; Zhang H; Lin G; Chen R; Kou L; Bao S Bioorg Med Chem Lett; 2021 Feb; 33():127728. PubMed ID: 33346010 [TBL] [Abstract][Full Text] [Related]
5. Toward targeted therapy in chemotherapy-resistant pancreatic cancer with a smart triptolide nanomedicine. Wang C; Liu B; Xu X; Zhuang B; Li H; Yin J; Cong M; Xu W; Lu A Oncotarget; 2016 Feb; 7(7):8360-72. PubMed ID: 26840019 [TBL] [Abstract][Full Text] [Related]
6. Synergism of cytotoxicity effects of triptolide and artesunate combination treatment in pancreatic cancer cell lines. Liu Y; Cui YF Asian Pac J Cancer Prev; 2013; 14(9):5243-8. PubMed ID: 24175808 [TBL] [Abstract][Full Text] [Related]
7. Galactosylated chitosan triptolide nanoparticles for overcoming hepatocellular carcinoma: Enhanced therapeutic efficacy, low toxicity, and validated network regulatory mechanisms. Zhang YQ; Shen Y; Liao MM; Mao X; Mi GJ; You C; Guo QY; Li WJ; Wang XY; Lin N; Webster TJ Nanomedicine; 2019 Jan; 15(1):86-97. PubMed ID: 30244085 [TBL] [Abstract][Full Text] [Related]
8. Triptolide augments the effects of 5-lipoxygenase RNA interference in suppressing pancreatic tumor growth in a xenograft mouse model. Ding X; Zhou X; Zhang H; Qing J; Qiang H; Zhou G Cancer Chemother Pharmacol; 2012 Jan; 69(1):253-61. PubMed ID: 21713446 [TBL] [Abstract][Full Text] [Related]
9. Aptamer-functionalized triptolide with release controllability as a promising targeted therapy against triple-negative breast cancer. Chen Y; Yang J; Wang C; Wang T; Zeng Y; Li X; Zuo Y; Chen H; Zhang C; Cao Y; Sun C; Wang M; Cao X; Ge X; Liu Y; Zhang G; Deng Y; Peng C; Lu A; Lu J J Exp Clin Cancer Res; 2024 Jul; 43(1):207. PubMed ID: 39054545 [TBL] [Abstract][Full Text] [Related]
10. Cytotoxicity of Triptolide and Triptolide loaded polymeric micelles in vitro. Zheng S; Löw K; Wagner S; Yang X; von Briesen H; Zou S Toxicol In Vitro; 2011 Dec; 25(8):1557-67. PubMed ID: 21640813 [TBL] [Abstract][Full Text] [Related]
11. The Inhibition Effect of Triptolide on Human Endometrial Carcinoma Cell Line HEC-1B: a in vitro and in vivo Studies. Ni J; Wu Q; Sun ZH; Zhong J; Cai Y; Huang XE Asian Pac J Cancer Prev; 2015; 16(11):4571-6. PubMed ID: 26107205 [TBL] [Abstract][Full Text] [Related]
12. Antitumor activity of triptolide in SKOV3 cells and SKOV3/DDP in vivo and in vitro. Hu H; Zhu S; Tong Y; Huang G; Tan B; Yang L Anticancer Drugs; 2020 Jun; 31(5):483-491. PubMed ID: 31972592 [TBL] [Abstract][Full Text] [Related]
13. The Anti-Tumor Mechanism and Target of Triptolide Based on Network Pharmacology and Molecular Docking. Zou T; Huang Y; Hu Y; Wu M; Zhao Y; Du F; Li M; Wu X; Ji H; Kaboli PJ; Wang S; Xiao Z; Wu Z Recent Pat Anticancer Drug Discov; 2021; 16(3):426-435. PubMed ID: 33573560 [TBL] [Abstract][Full Text] [Related]
14. Acute and subacute toxicity studies on triptolide and triptolide-loaded polymeric micelles following intravenous administration in rodents. Xu L; Qiu Y; Xu H; Ao W; Lam W; Yang X Food Chem Toxicol; 2013 Jul; 57():371-9. PubMed ID: 23583804 [TBL] [Abstract][Full Text] [Related]
15. Triptolide-loaded nanoparticles targeting breast cancer in vivo with reduced toxicity. Zheng W; Wang C; Ding R; Huang Y; Li Y; Lu Y Int J Pharm; 2019 Dec; 572():118721. PubMed ID: 31626922 [TBL] [Abstract][Full Text] [Related]
16. Anti-tumour and immuno-modulation effects of triptolide-loaded polymeric micelles. Xu L; Chen H; Xu H; Yang X Eur J Pharm Biopharm; 2008 Nov; 70(3):741-8. PubMed ID: 18761405 [TBL] [Abstract][Full Text] [Related]
17. Enhancement of triptolide-loaded micelles on tumorigenicity inhibition of human ovarian cancer. Wang Y; Liu T; Li H J Biomater Sci Polym Ed; 2016; 27(7):545-56. PubMed ID: 26786618 [TBL] [Abstract][Full Text] [Related]
18. Triptolide-induced in vitro and in vivo cytotoxicity in human breast cancer stem cells and primary breast cancer cells. Li J; Liu R; Yang Y; Huang Y; Li X; Liu R; Shen X Oncol Rep; 2014 May; 31(5):2181-6. PubMed ID: 24676587 [TBL] [Abstract][Full Text] [Related]
19. Enhanced antitumor effect of combined triptolide and ionizing radiation. Wang W; Yang S; Su Y; Xiao Z; Wang C; Li X; Lin L; Fenton BM; Paoni SF; Ding I; Keng P; Okunieff P; Zhang L Clin Cancer Res; 2007 Aug; 13(16):4891-9. PubMed ID: 17699869 [TBL] [Abstract][Full Text] [Related]
20. Triptolide exhibits antitumor effects by reversing hypermethylation of WIF‑1 in lung cancer cells. Mao X; Tong J; Wang Y; Zhu Z; Yin Y; Wang Y Mol Med Rep; 2018 Sep; 18(3):3041-3049. PubMed ID: 30015908 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]